Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
Impact in
- Physiology 183
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w21043871 →Countries where authors are citing Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
This map shows the geographic impact of Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. more than expected).
Fields of papers citing Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
This network shows the impact of Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study..
About Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
This paper, published in 1994, received 510 indexed citations . Written by Nicholas R. Anthonisen, John E. Connett, James P. Kiley and Richard E. Kanner covering the research area of Pulmonary and Respiratory Medicine. It is primarily cited by scholars working on Pulmonary and Respiratory Medicine (363 citations), Physiology (183 citations), Emergency Medical Services (31 citations), Public Health, Environmental and Occupational Health (24 citations) and Molecular Biology (18 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w21043871.